Showcasing its digital pathology cockpit and workflow solution in booth #4 at the Association of Pathology Chairs (APC) Annual Meeting in San Diego July 12th -15th, Inspirata also will be hosting a 2-hour expert panel on overcoming the barriers to digital pathology adoption.

Tampa, FL, July 8, 2016/PRWeb – Cancer diagnostics and digital pathology workflow solution provider Inspirata, Inc., announced today that it is a Diamond Sponsor and exhibitor at the Association of Pathology Chairs (APC) annual meeting in San Diego next week. During the meeting, Inspirata will be exhibiting its Digital Pathology Cockpit and Workflow Solution. The company also is hosting a two-hour pre-conference workshop and panel discussion from 10:00 a.m. to noon on July 12th immediately followed by lunch for attendees.

The workshop panel is a lineup of “who’s who” in digital pathology, with expertise spanning all aspects of digital pathology, including productivity gains, infrastructure requirements, regulatory issues, image analysis and computer vision algorithms, personalized diagnostics and big data. The workshop keynote address is being delivered by the President of the College of American Pathologists (CAP) Richard C. Friedberg, MD, PhD, FCAP. Inspirata’s Dr. Mark Lloyd will then give an overview of the challenges that are creating barriers to digital pathology adoption and explain how to overcome them. Then a panel of six subject matter experts will discuss key digital pathology topics and answer questions from the audience. Panelists include Ulysses Balis, MD, University of Michigan; David Dimond, CTO, EMC Corporation; Michael Feldman, MD, PhD, University of Pennsylvania; Richard Friedberg, MD, PhD, Baystate Health; Anant Madabhushi, PhD, Case Western Reserve University; and John Tomaszewski, MD, State University of New York at Buffalo.

In the exhibit hall, which is open Tuesday through Thursday, Inspirata will conduct ongoing demonstrations of its Digital Pathology Cockpit, including new functionality spanning image analysis directed review and informed detection tools. Additionally, Inspirata will showcase its end-to-end digital pathology workflow solution and explain how its new Enterprise Service Bus (ESB) supports interoperability between the various heterogeneous systems in hospitals.

“Our comprehensive digital pathology solution combined with our unique business model are designed to enable cancer centers to make the financial case and quickly move to an automated workflow and begin leveraging the many benefits digital pathology has to offer, including generating new revenue streams through telepathology,” says Inspirata CEO Satish Sanan. “Our two-hour pre-conference workshop at APC will delve into the myriad aspects of digital pathology adoption, including how it can help pathologists do their jobs better and faster, with the goal of improving patient care.”

About APC

The Association of Pathology Chairs (APC) is a non-profit society, which serves as the voice of academic departments of Pathology in the U.S., Canada and Puerto Rico. APC exists to provide leadership and advocacy for the dynamic discipline of Pathology and to enable academic departments to meet the demands of their three missions: medical education, research and practice. The APC provides education, training, information resources and networking opportunities for chairs, residency program directors (through PRODS), medical student educators (through UMEDS), department administrators (through PDAS), and program coordinators (through GMEAS). For more information, please visit http://www.apcprods.org/.

About Inspirata, Inc.

Inspirata, Inc. provides a cancer diagnostics solution that digitizes and automates the entire pathology workflow using a unique, “solution-as-a-service” delivery model. This comprehensive solution helps to solve interoperability issues, and includes workflow automation and diagnostic tools to help pathologists work more efficiently. Inspirata’s diagnostic tools include algorithms that extract relevant image-based information from digitized histology specimens for use as supplemental screening aids to assist pathologists with cancer detection and prediction of disease progression and therapeutic responses. For more information, please visit www.inspirata.com or contact info@inspirata.com.

OR

platinum partners

gold partners

Silver Partners

Media Partners